Ofatumumab
CAS No. 679818-59-8
Ofatumumab( —— )
Catalog No. M22156 CAS No. 679818-59-8
Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 558 | In Stock |
|
| 10MG | 805 | In Stock |
|
| 25MG | 1226 | In Stock |
|
| 50MG | 1609 | In Stock |
|
| 100MG | 2167 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOfatumumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionOfatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation.
-
DescriptionOfatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number679818-59-8
-
Formula Weight149 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Barth MJ, et al.Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma.Clin Cancer Res. 2015 Oct 1;21(19):4391-7.
molnova catalog
related products
-
Methyl 13-cis-4-Oxor...
4-Keto 13-cis-Retinoic Acid is a retinoic acid metabolite in neuroblastoma.
-
DS-1040 tosylate
DS-1040 tosylate (DS1040)?is a small molecule inhibitor of the activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50 of 1.7 ng/mL for rabbit TAFIa.
-
PH-002
PH-002 is an inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction in neuronal cells. It also could rescue impairments of mitochondrial motility and neurite outgrowth.
Cart
sales@molnova.com